Thursday, May 23, 2024
wellness India Expo
Home Tags China

Tag: China

Does China’s leading place in the global MedTech market reflect the...

Naturally, given the potential riches on offer, many western MedTech multinationals are now tailoring their R&D and manufacturing strategies to align with the Chinese market's unique needs and government initiatives

Nasovac-S4 offers defence against recent surge in respiratory illnesses, say experts

NASOVAC-S4, India’s first exclusive needle-free flu vaccine, is administered through the nasal route, offering a non-invasive and painless alternative to traditional injections

Agri testing services market growth to enrich with better productivity &...

Future Market Insights states that Asia Pacific excluding Japan is anticipated to account for a significant share in the global agricultural testing services market from the forecast period 2023 to 2033

MTaI recommends Japan as the “China+1 alternative in MedTech imports

Increase in MedTech imports from China by 57% in FY 21-22 raise concerns

Chinese regulators focus on homegrown COVID-19 therapies to tackle new variants,...

According to GlobalData’s Pharma Intelligence Center, there are currently 16 COVID-19 drugs in clinical development in China, five of which are in Phase III

Vaccines with efficacy against Omicron variants will gain competitive advantage in...

According to GlobalData’s Pharma Intelligence Center, there are currently 19 COVID-19 vaccines in clinical development in China, with only 3 candidates in Phase III trials

NAFLD clinical trial activity catching up in China, mostly driven by...

China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade

Heart attack diagnostics market sales create significant incremental opportunity over 2032

In the test sector, blood tests from the heart attack diagnostics market are anticipated to flourish at the quickest CAGR of 6.8% through 2032

China focuses on next-generation intranasal COVID-19 vaccines amid rising mutant strains

Several pharmaceutical companies across the world have started working on the inhaled vaccine formulations and China is also developing next-generation intranasal COVID-19 vaccines, says GlobalData....................

Pharma sector revenue to remain healthy at 8-11% in FY-2022: ICRA

Minimal impact of Covid-19 on the Indian pharmaceutical industry owing to inelastic demand for drugs coupled with continued supply of APIs/KSM from China, which accounts for 60% of industry requirement......................